INTRODUCTION
Many studies have been carried out wherein individual genes are manipulated and their effects on cell types characterized. In most instances, these are transcription factors or elements of a signaling pathway (Afelik and Jensen, 2013; Lee and Pfaff, 2001; Nakajima, 2011) . The expression patterns of many of these genes, and their effects, are often spread across many cell types. Nevertheless, they are able to play specific roles in different times and places. The consensus is that specific outcomes are due to different contexts in different cells (Kamachi and Kondoh, 2013) . Chromatin structure, microRNAs, and other transcripts and proteins undoubtedly create such contexts. However, studies that define a particular context are difficult and, for the most part, have not been carried out. To dissect such complexities, it is useful to have a system by which one can manipulate gene expression, ideally in vivo. In addition, a system in which one can readily discover the cis-regulatory sequences required for gene regulation is advantageous. The murine retina offers such a system (Kim et al., 2008a; Cepko, 2004, 2007) . We have exploited this system to address a binary fate decision in the mammalian retina.
The retina is a highly evolved sense organ, which uses photoreceptors to capture light and create neural signals that are transmitted to other retinal neurons. Parallel processing of these visual signals is carried out by more than 60 retinal cell types to extract selected features from the visual scene (Masland and Raviola, 2000; Meister, 1996) . There are a large number of inherited diseases of the retina, most due to dysfunction and loss of photoreceptor cells (Boucherie et al., 2011) . An understanding of the specification of retinal neurons can greatly inform the development of therapies to treat such diseases, e.g., the production of photoreceptor cells from stem cells (Ong and da Cruz, 2012) .
During retinal development, retinal cell types are specified from a pool of multipotent retinal progenitor cells (RPCs) in a temporal order (Livesey and Cepko, 2001) . RPCs can produce two very different cell types in a terminal division. One such division produces a rod photoreceptor cell and an interneuron, the bipolar cell (Turner and Cepko, 1987) . There have been several studies that have identified transcription factors (TFs) that impact these two fates (Brzezinski et al., 2010; Jia et al., 2009; Katoh et al., 2010; Koike et al., 2007; Ohsawa and Kageyama, 2008; Sato et al., 2007) . Many of these genes impact more retinal cell types than just the rods and bipolar cells. We wished to understand the gene regulatory network (GRN) operating within the RPCs and their newly postmitotic progeny at the time when this rod versus bipolar cell binary decision is being made. Binary cellfate decisions have been well studied in invertebrates and in vertebrate hematopoiesis (Graf and Enver, 2009; Jukam and Desplan, 2010) . However, in the mammalian central nervous system (CNS), including the retina, the TFs that control cell-fate decisions have been mainly studied by gain-and loss-of-function manipulations of individual TFs. The participation of TFs within a GRN and the cis-regulatory modules (CRMs) that they utilize have not been systematically addressed. Here, we have identified interactions of key TFs that regulate the final ratio of rods versus bipolar cells within the rod-bipolar GRN, based on the identification of a CRM for Blimp1, a gene that is important in this GRN. We also used in vivo electroporation to interrogate the necessity of this CRM, after first testing CRISPR/Cas9 (Cong et (legend continued on next page)
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The GRN for Retinal Cell Fate Specification reporter strain of mice to determine the effectiveness of this method to create genomic alterations in tissues. We found that CRISPR/Cas9 created homozygous and heterozygous alterations in >50% of the electroporated retinal cells. This method was then employed for deletion of the Blimp1 CRM, where it led to the loss of Blimp1 function. Together, all of these experiments led to the identification of the GRN that regulates the rod versus the bipolar fate. The GRN regulates the level of Otx2, a gene that is required for the production of both rods and bipolar cells, whose level determines whether a cell becomes a rod or a bipolar cell.
RESULTS

Identification of Retinal Enhancers of the Blimp1 Gene
Blimp1, a zinc-finger transcription factor (also known as Prdm1), has been shown to be required for the production of the proper ratio of rods and bipolar cells, as its loss leads to an increase in bipolar cells and a reduction in rods (Brzezinski et al., 2010 (Brzezinski et al., , 2013 Katoh et al., 2010) . As the first step in the dissection of the rod-bipolar GRN, we sought to identify the critical CRMs that control Blimp1 expression in the retina. DNA fragments upstream of the Blimp1 transcription start site (TSS) were tested for their ability to activate expression of reporter genes in developing mouse retinas, using electroporation into retinal explants. An $12 kb mouse genomic fragment (B12kb) was able to drive expression in retinas, and thus a series of deletions were tested to determine the minimal sequence for this activity (Figure 1) . A 108 bp fragment (B108) was found to be sufficient to drive reporter expression in retinas (Figure 1 ; Figure S1 available online). B108 was also necessary for the activity of B12kb, as deletion of this fragment dramatically reduced EGFP expression driven by B12kb (Figures 2A-2D ). Expression driven by the B108 enhancer was analyzed for fidelity of expression by comparing it with that of the native Blimp1, which is transiently expressed. From postnatal day 0 (P0) to P3, Blimp1 is broadly expressed in many retinal cells. Later, its expression is downregulated, becoming undetectable by antibody staining and northern blot assay after P7 (Brzezinski et al., 2010; Katoh et al., 2010) . The expression pattern of EGFP driven by B108 was examined relative to immunohistochemistry (IHC) for Blimp1 at different developmental stages. When the B108 reporter was electroporated into retinas in vivo at P0, $90% of EGFP + cells were positive for Blimp1 IHC signals by P3 (Figures 2A-2D ). Consistent with endogenous Blimp1 expression pattern, EGFP expression driven by B108 was downregulated beginning at P7 ( Figure S2A ). We could detect low EGFP expression in rods after P7 if anti-GFP antibody was used to amplify the signal, possibly because of the greater stability of EGFP proteins/mRNAs relative to Blimp1 and/or missing elements that are responsible for downregulation of Blimp1 within B108 ( Figure S2B ). To investigate one possible element for downregulation, we tested whether the addition of the Blimp1 3 0 UTR to the B12kb construct would lead to a reduction in expression ( Figure S7A ). Indeed, a significant reduction was seen, in keeping with previous studies of Blimp1 regulation in other tissues, which showed that microRNAs downregulate Blimp1 through 3 0 UTR sites (Nie et al., 2008; West et al., 2009; Zhang et al., 2011) . In addition, as Blimp1 has been shown to negatively regulate its own expression, we coelectroporated CAG-Blimp1 with the B12kb reporter plasmid and again observed evidence of negative regulation ( Figure S7B ). Overall, the onset of expression and the cells that activated the B108 enhancer recapitulated the endogenous expression of Blimp1 during early postnatal retina development, and additional elements within a larger regulatory region of Blimp1 are responsible for fine-tuning the downregulation.
Blimp1 has been reported to be expressed predominantly in postmitotic cells in the developing retina (Brzezinski et al., 2010; Katoh et al., 2010) . We thus investigated whether B108 activated EGFP expression in postmitotic cells by using EdU, a thymidine analog, to mark cells in S phase. EGFP + cells were rarely found to be EdU + 1 hr after EdU administration, demonstrating that B108 was not active in S phase retinal cells (Figure S2D) . We further addressed whether B108 would be active in G2 or M phase by an EdU pulse-chase assay. In the postnatal developing retina, the cell-cycle length of mitotic progenitors is roughly 30 hr (S phase: 16 hr; G2 phase: 3 hr; M phase: 2 hr; G1 phase: 8 hr) (Young, 1985b) . Following a short pulse of EdU and a 20 hr chase, the majority of EdU + cells should be in G1/ G0 phase ( Figure S2C ). Analysis of cells after a 20 hr chase showed that most EdU + cells (in G1/G0 phase) had not turned on EGFP expression, suggesting that they needed more time to activate B108 ( Figure S2D ). These experiments further validate the B108 enhancer, as it predominantly drives expression in postmitotic cells of the postnatal retina, consistent with the timing of Blimp1 activation. Lastly, a recent study used the Blimp1-Cre BAC-transgenic mouse to trace cells with a Blimp1 expression history. Nearly all photoreceptors, about 30% of bipolar and amacrine cells, roughly half of horizontal cells, and very few Mü ller glial cells showed a history of Blimp1 expression (Brzezinski et al., 2013) . We were interested in the fate of the cells that activated the B108 enhancer. Because B108 activity was downregulated as the cells matured, we needed to use a history assay to determine which cell fates were marked by the transiently active B108 enhancer. To this end, we used B108 to drive Cre expression. A control construct with no enhancer led to very few cells with Cre history ( Figure 2E ). Cells that activated B108 primarily became rods, with a few becoming amacrine and Muller glial cells, but almost no bipolar cells ( Figures  2E-2K ). This demonstrated that B108 preferentially tracked the postnatal Blimp1-expressing cells that adopted the rod photoreceptor fate.
(B) An $12 kb fragment (B12kb) upstream of the Blimp1 gene and a variety of deletion variants were inserted upstream of the EGFP gene in a reporter plasmid and electroporated into mouse retinas, with assessment of EGFP levels indicated on the left. An $1 kb fragment (Chr10: 44464199-44465247; GRCm38/mm10) is critical for activity. (C) A series of truncations of the $1 kb fragment were generated based on sequence conservation. These fragments were cloned into the Stagia3 reporter plasmid individually and tested for activity, as summarized on the left. See also Figure S1 . 
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These results demonstrate that the B108 enhancer drives expression in a manner that substantially mimics the endogenous Blimp1 expression in the developing postnatal mouse retina, during the period when rod photoreceptors and bipolar cells are born.
CRISPR/Cas9-Based Genome Engineering Demonstrates that B108 Is Necessary for Endogenous Blimp1 Expression To gain a better understanding of the regulation of the endogenous Blimp1 gene, we investigated whether B108 was required for endogenous Blimp1 expression. With the recent advance of the RNA-guided genome engineering technique, using CRISPR/Cas9, targeted engineering of genomic DNA has the potential to allow a rapid assessment of CRMs within the genome (Cong et al., 2013; Mali et al., 2013; Sternberg et al., 2014) . We thus tested whether CRISPR/Cas9 could effectively allow engineering of the mouse genome in vivo in the retina.
The general efficiency of CRISPR/Cas9 in mouse retinas was examined using the Rosa mTmG/mTmG mouse strain, which is a
Cre reporter knockin line that utilizes both GFP and Tdtomato reporters (Muzumdar et al., 2007) . This line expresses membrane GFP (mGFP) in tissues following the Cre-mediated excision of the membrane Tdtomato (mTdtomato) cassette ( Figure S3A ). We constructed a CRISPR/Cas9 plasmid CRISPRmTmG to specifically generate DNA double-stranded breaks near both LoxP sites, by inserting 20 bp targeting sequences into the CRISPR/Cas9 vector plasmid (Px330), which expresses both Cas9 and guide RNAs in one plasmid (for detailed procedures, please see the Protocol). Upon successful cleavage, the ends of the cleaved DNA are predicted to ligate to each other via the nonhomologous end-joining (NHEJ) DNA repair pathway, resulting in the deletion of the mTdtomato cassette and the switching on of the mGFP expression. The CRISPRmTmG plasmid was introduced into retinas of Rosa mTmG/mTmG mouse pups in vivo at P0 by electroporation. After 21 days, in the electroporated region, a significant number of retinal cells turned on mGFP expression, suggesting that CRISPRmTmG successfully deleted the mTdtomato cassette from the genome ( Figure S3B ). Roughly 80% of rods, 30% of bipolar cells, 70% of Muller glial cells, and 40% of amacrine cells, which received the CRISPRmTmG plasmid, turned on mGFP expression. Given the relatively high efficiency of CRISPR/Cas9 in the retina in vivo, we next investigated whether we could delete the B108 enhancer from the genomic locus. CRISPR/Cas9 plasmids were constructed to generate double-strand breaks 5 0 and 3 0 to B108 in the mouse genome, and PCR primers were designed to detect the deletion ( Figure 3A ). To assay whether the CRISPR/Cas9 plasmids could delete B108, retinal cells were electroporated in vivo with CRISPR/Cas9 plasmids and an EGFP coelectroporation marker ( Figure 3B ). Genomic DNA was prepared from fluorescence-activated cell sorting (FACS)-sorted EGFP + retinal cells and was subjected to PCR. A smaller PCR fragment, the size predicted for the B108 deletion, was observed only when this locus was targeted (the L band in Figure 3B) . Sequencing of the L band PCR fragments as a population revealed that the majority of the cleavage events directed by the CRISPR/Cas9 plasmids, B51 and B33, were at positions 3 bp 5 0 to the PAM sequence, as predicted for CRISPR/Cas9 activity ( Figure 3C ) (Cong et al., 2013) . To further investigate the distribution and types of sequence changes in the targeted region, both the H band, which corresponded to the wild-type (WT) size, and the L band were cloned, and individual clones were sequenced (Figures 3B, S3C, and S3D). The majority of products in the L band were as seen in the bulk population sequence analysis, that is, the same result shown in Figure 3C . In addition, there were single cleavage events recorded in the products from the H band, and a few other insertions and deletions were seen in a minority of the products cloned from the H and L bands (Figures S3C and S3D) . These results demonstrated that CRISPR/ Cas9 could be used to assess the requirement for B108 in regulation of Blimp1 in vivo.
Blimp1 conditional knockout (CKO) mice have been shown to have an increase in bipolar cells and a decrease in rod photoreceptors (Brzezinski et al., 2010; Katoh et al., 2010) . If the B108 enhancer is required for Blimp1 expression, then the CRISPR/ Cas9-mediated deletion of B108 should recapitulate the CKO phenotype. The lack of molecular markers that label cells with successful CRISPR/Cas9 deletion, and the fact that the loss-offunction phenotype is apparent only after Blimp1 expression is downregulated, made it difficult to assess the phenotype of cells that had lost the B108 enhancer. Thus, we used the Cre recombinase-based fate-mapping strategy and examined whether the production of bipolar cells was increased upon B108 deletion. We were able to follow cells that took on the bipolar fate following CRISPR/Cas9 action using a reporter plasmid for bipolar cells.
To report bipolar cell identity, the Cre-sensitive reporter plasmid Chx10BP-LCL-EGFP was constructed ( Figure 3D ). This reporter plasmid not only labels bipolar cells specifically but it also switches expression of fluorescent reporter genes following Cre-mediated excision. A previously identified Chx10 enhancer that is only active in bipolar cells was used to drive fluorescent protein expression (Emerson and Cepko, 2011; Kim et al., 2008a . Vector: plasmid combinations in (E). CAG: plasmid combination in (F). B108: plasmid combination in (G). Error bars, SEM. Two-tailed Student's t test (*p < 0.01; **p < 0.001). n R 3. Scale bar, 10 mm. See also Figure S2 . 
The GRN for Retinal Cell Fate Specification ( Figure 3D ). Following Cre-mediated excision of mCherry, EGFP would be expressed. To test this construct as a reporter of B108-Cre activity, the B108-Cre plasmid was delivered into P0 retinas in vivo along with the Chx10BP-LCL-EGFP reporter. Consistent with our previous experiment, most bipolar cells were labeled by mCherry; i.e., they did not have a history of activating B108-Cre ( Figures 2G, 3F , and 3G). To determine if deletion of the endogenous B108 element from the endogenous Blimp1 gene would result in a phenotype consistent with the Blimp1 CKO phenotype, the Blimp1 B108 CRISPR/Cas9 plasmids (B51+B33 or B53+B31), along with the B108-Cre and Chx10BP-LCL-EGFP plasmids, were electroporated into P0 retinas in vivo, and the expression of the Chx10BP-LCL-EGFP reporter was assessed at P14 ( Figure 3E ; for detailed procedures, please see the Protocol). The B108-Cre plasmid does not encode the PAM sequence or the CRISPR/Cas9 target sites and so would be unaffected by the CRISPR/Cas9 activity. In contrast to a no CRISPR/Cas9 control, a significant number of EGFP + bipolar cells were observed when the endogenous B108 was targeted ( Figures  3F and 3G ). This result phenocopies the Blimp1 CKO result, wherein more bipolar cells are generated in the absence of Blimp1, demonstrating the necessity of the B108 enhancer for proper Blimp1 regulation in the retina. This result also demonstrates that the cell-fate change seen following loss of Blimp1 is a cell-autonomous effect.
Identification of Critical Transcription Factor Binding Sites in the B108 Enhancer
In order to understand the transcriptional regulation of Blimp1, the B108 enhancer was subjected to a series of analyses to identify transcription factor binding sites (TFBSs) and their cognate TFs. We first examined the B108 sequence for sequence conservation and then searched for putative TFBSs within the conserved sequences. B108 showed high sequence conservation among several species, ranging from zebrafish to human, with some stretches of nucleotides showing 100% conservation (Figures 1 and S4 ). These highly conserved stretches appeared in clusters, which further suggested they might be functional regulatory regions (Arnone and Davidson, 1997; Berman et al., 2002; Wasserman and Fickett, 1998) . To test for function, selected clusters were mutated individually, and these mutated reporters were electroporated into retinas to assess reporter activity. Two of these mutations significantly decreased enhancer activity compared with the wild-type B108 (RORm and Otxm; Figure S4 ). These two clusters were each deleted, and the deletion constructs also showed a loss-of-enhancer activity (DROR and DOtx2; Figure S4 ). Analysis of these two sequences for TFBSs by the rVista program and TRANSFAC algorithms suggested that these two sites corresponded to the binding sites of RORb and Otx2/Crx (Loots and Ovcharenko, 2004; Matys et al., 2006) . To test the sufficiency of the RORb and Otx2/Crx binding sites, they were tested for their ability to drive EGFP in retinas in the absence of other B108 sequences. These two TFBSs were able to drive strong EGFP expression in the retina (ROx2; Figure S4 ).
RORb and Otx2 Regulate Blimp1 Expression via the B108 Enhancer
We examined whether RORb and Otx2/Crx were indeed upstream regulatory TFs of Blimp1 by addressing whether RORb and Otx2/Crx were necessary for the activation of B108 and the endogenous Blimp1 gene. We generated plasmids with short hairpin RNAs (shRNAs) that could efficiently knock down RORb, Otx2, Crx, or control LacZ expression ( Figure S5 ). These shRNA constructs were designed based on microRNA structures that allowed for the use of PolII promoters, such as the CAG promoter, and were located within the 3 0 UTR of mCherry, which allowed for the tracking of shRNA expression via expression of mCherry ( Figure S5A ) (Qiu et al., 2008) .
When either the RORb-shRNA or Otx2-shRNA plasmids were introduced into retinas, the activity of the B108-EGFP reporter was dramatically decreased compared with controls within 24 hr ( Figures 4A and 4B ). In contrast, knockdown of Crx did not affect the activity of B108. These results suggested that RORb and Otx2 were required for the activation of B108. To further investigate the requirement of Otx2, an Otx2
Flox/Flox conditional mouse strain was used. Electroporation of this strain with B108-EGFP reporter and Cre showed a significant reduction in the activity of B108 ( Figure 4C ). To explore whether RORb and Otx2 could directly bind to B108, we performed electrophoretic mobility shift assay (EMSA) (Figures 4D and 4E) . The fragments within B108 that contained RORb or Otx2 binding sites were used as DNA probes. Strong electrophoretic mobility bands were detected when the wild-type RORb probe was mixed with RORbenriched nuclear extracts from 293T cells or wild-type P3 retina nuclear extracts. When RORb antibody was incubated with EMSA probes and retina nuclear extracts, the primary EMSA band disappeared, suggesting that the RORb antibody prevented the binding of RORb proteins to labeled DNA probes. Furthermore, when the RORb binding site was mutated in the EMSA DNA probe, no shifted band was detected, demonstrating the specificity of the binding (Figures 4D and 4E) . Similar results were observed for Otx2, demonstrating that the regulation of B108 is likely through direct binding of Otx2 and RORb. 
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The GRN for Retinal Cell Fate Specification (A) Knockdown of RORb and Otx2 reduced B108 activity. Plasmids that contained different shRNA cassettes were electroporated into P0 retinas ex vivo with B108-EGFP (2:1 ratio) and the electroporation efficiency control CAG-mCherry. Two different shRNA constructs were used for knocking down RORb or Otx2. Retinas were cultured as explants for 24 hr and examined. Scale bar, 1 mm. (B) Quantification of B108 activity. The ratio of total EGFP intensity over mCherry intensity was calculated (Fiji software) and normalized to LacZ-shRNA controls. Error bars, SEM. Two-tailed Student's t test (*p < 0.01). n R 4. (C) The experimental design to test whether Otx2 is required for the activation of B108. Indicated combinations of plasmids were electroporated into P0 Otx2 Flox/Flox retinas ex vivo. Retinas were cultured as explants for 24 hr and examined. Scale bars, 500 mm.
(D and E) EMSA. Probe sequences are shown. CAG-LacZ, CAG-Otx2, or CAG-RORb lysates: nuclear extracts of 293T cells that were transfected with CAG-LacZ, CAG-Otx2, or CAG-RORb plasmid. P3 retina lysate: nuclear extracts of P3 mouse retinas. Anti-GFP antibody was used as a negative control. Anti-RORb and antiOtx2 antibodies were included as indicated. See also Figures S4 and S5 .
We further examined whether RORb or Otx2 were required for the activation of the endogenous Blimp1 gene. As loss of function of either Otx2 or RORb leads to changes in retinal cell types, we wished to assay whether reduction in the expression of these TFs would affect Blimp1 expression, without the confound of changes in retinal cell types. In addition, as electroporation does not target a large number of cells, and there is a great deal of heterogeneity in the population of cells that are electroporated, we preferred a method that could be applied to individual cells to measure mRNA levels. To this end, we used single-molecule fluorescent in situ hybridization (FISH) (Raj and van Oudenaarden, 2009 ). This technique uses numerous DNA probes (each probe is $20 bp long and conjugated directly with fluorophores) to detect a single mRNA molecule in situ. The hybridized probes produce a single fluorescent dot on a single mRNA molecule ( Figures 5A  and 5D ). Quantification of the number of dots per cell provides a measure of the relative mRNA levels for the target gene. We utilized this technique to detect Blimp1 mRNA levels after shRNA knockdown of RORb or Otx2. Otx2-shRNA, RORb-shRNA, or LacZ-shRNA were placed 3 0 to the EGFP gene and only EGFP + retinal cells were quantified. Single-molecule FISH probes for RORb mRNA, Otx2 mRNA, or Blimp1 mRNA levels were utilized ( Figure 5 ). Twenty-four hours after shRNA plasmids were electroporated into retinas, when many retinal cells would still be in the same cell cycle (retinal cell-cycle length: $30 hr), FISH was performed for all three genes in individual EGFP + retinal cells.
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In the presence of RORb-shRNA, significantly fewer retinal cells had a high number of RORb signals compared with the LacZ-shRNA control, demonstrating that the RORb-shRNA could successfully knock down endogenous RORb levels within 24 hr (Figures 5A and 5B ). More importantly, significantly fewer retinal cells had a high number of Blimp1 signals when RORb expression was targeted (Figures 5A and 5C ). Similar experiments were performed with the Otx2-shRNA. Compared with controls, significantly fewer retinal cells contained a high number of Otx2 signals and Blimp1 signals when the Otx2-shRNA was introduced ( Figures 5D-5F ). These data demonstrate that RORb and Otx2 are positive regulators of endogenous Blimp1 expression.
Blimp1 and Otx2 Form a Negative Feedback Loop to Ensure Proper Rod Photoreceptor Formation
When examining the relationship between Otx2 and Blimp1, we discovered two Blimp1 binding sites (AGNGAAAG) in a 5 0 region of a 600 bp Otx2-enhancer element, ECR2, that we previously showed to be active in developing photoreceptors ( Figure S6A ) (Emerson and Cepko, 2011; Katoh et al., 2010) . Given that Blimp1 predominantly functions as a transcriptional repressor (John and Garrett-Sinha, 2009 ), we investigated whether Blimp1 could repress the activity of the Otx2ECR2 enhancer. Electroporation of the Otx2ECR2 reporter and a Blimp1 expression plasmid revealed that the activity of ECR2 was significantly inhibited by Blimp1 overexpression (Figures S6B and S6C) . Disruption of one of the Blimp1 binding sites released the repression of Blimp1 on ECR2 (Figures S6C and S6D) . EMSA further showed that Blimp1 could directly bind to the Otx2ECR2 enhancer ( Figure S6E ). These data demonstrated that Blimp1 and Otx2 can form a negative-feedback loop, which might be required for the genesis of the proper ratio of rod and bipolar cells at postnatal stages.
In mature retinas, rod photoreceptors express low levels of Otx2, whereas bipolar cells express high levels of Otx2 (Fossat et al., 2007) . In addition, the majority of Blimp1 + cells in the postnatal retina develop into rod photoreceptors (Figures 2G and 2H) (Brzezinski et al., 2013) . These two observations, and that of Blimp1-mediated repression of Otx2 described above, suggested that the expression level of Otx2 might be repressed by Blimp1 and that the level of Otx2 might play a role in the specification of these two cell types. To test this hypothesis, B108 was used to drive constant high levels of Otx2 expression in Blimp1-expressing cells, whose fates were then traced.
As used previously in the experiment described in Figure 3 , the Cre-sensitive bipolar reporter plasmid, Chx10BP-LCL-EGFP, was used to report bipolar cells ( Figure 3D ). When Cre-expressing cells become bipolar cells, they turn on EGFP expression, whereas bipolar cells with no history of Cre are marked by mCherry ( Figures 3F, 6A , and 6B). In controls, B108 was used to drive only Cre expression. Consistent with our previous observation, very few EGFP + bipolar cells were observed, demonstrating that cells that activated B108-Cre do not usually adopt bipolar cell fates ( Figures 2G-2K, 3F , and 6C). To drive sustained ectopic Otx2 expression only in Blimp1 + cells, the B108-Otx2-IRES-Cre plasmid was constructed, to express Otx2 and Cre at the same time under the control of B108. Cre could delete the mCherry cassette within the Chx10BP-LCL-EGFP reporter, leading to EGFP + bipolar cells. Following introduction of B108-Otx2-IRES-Cre along with the bipolar Chx10BP-LCL-EGFP reporter in vivo into P0 retinas, a significant number of EGFP + bipolar cells were observed at P14 (Figures 6D and 6E ). This result illustrated that high levels of Otx2 significantly increased the probability that Blimp1 + cells, which normally adopt the rod fate, now adopt the bipolar cell fate. To further investigate the Otx2 dose-sensitivity for the rod versus bipolar fate decision, Otx2 levels were reduced by shRNA in vivo. This led to the formation of more rods and fewer bipolar cells ( Figure 6F ). In contrast, when retroviruses that expressed Otx2 and a marker gene, human placental alkaline phosphatase (PLAP), were used to infect retinas at P0 in vivo, the number of bipolar cells was significantly increased compared with controls ( Figure 6G) . A retrovirus construct designed to overexpress Otx2 was previously used for a similar experiment in the retina, with the result that bipolar cells were reduced (Nishida et al., 2003) . We obtained this retroviral construct but were unable to repeat Nishida et al.'s result with their retrovirus construct.
DISCUSSION
This study aimed to understand the GRN that regulates one of the binary cell-fate specification events in the postnatal retina. We focused specifically on the decision to become a rod or a bipolar cell within a particular time window, P0-P3, during which this decision is being made in siblings of a terminal division (Turner and Cepko, 1987) . The study was initially focused on Blimp1, a node in the rod-bipolar GRN. Identification of a small element, B108, allowed for the discovery of the regulators of this gene and provided a starting point for the interrelationships among other elements in this GRN. The model shown in Figure 7 summarizes our current understanding of the rod-bipolar GRN. At postnatal stages, RORb and Otx2 initiate Blimp1 expression in RPCs that are about to produce postmitotic daughter cells. As the level of Blimp1 rises, there is direct negative feedback on Otx2, and Blimp1 negatively regulates its own expression ( Figure S7B) , as has been shown in other systems (Magnú sdó ttir et al., 2007; Smith et al., 2007) . Cells that experience the drop in Otx2 levels enter into the rod pathway. An additional arm of the GRN ensures that See also Figure S6 .
Developmental Cell
The GRN for Retinal Cell Fate Specification the cells with a high Blimp1 level do not enter into the bipolar pathway. Previous studies showed that Blimp1 also represses Chx10, a TF that is essential for bipolar cell genesis (Burmeister et al., 1996; Katoh et al., 2010) . As a result of these repressive activities of Blimp1, the expression levels of Otx2 and Chx10 are reduced, which favors the rod fate. Additional support for this model comes from misexpression of Otx2, which results in overproduction of bipolar cells, likely at the expense of rod photoreceptors ( Figure 6G ), and previous work showed the same result when Chx10 was overexpressed (Livne-Bar et al., 2006) . Similarly, reduction of Blimp1 expression leads to overproduction of bipolar cells (Brzezinski et al., 2010; Katoh et al., 2010) , most likely through the resulting upregulation of Chx10 and Otx2. In cells that will adopt the bipolar fate, it is possible that Blimp1 expression is also initiated by RORb and Otx2, as these two TFs are expressed in bipolar cells (Chow et al., 1998; Fossat et al., 2007) . However, as Blimp1 is not expressed at detectable levels in bipolar cells, it may not be activated in these cells, or it is quickly repressed following activation, by as yet undefined repressive effects in bipolar cells. An additional element of this GRN involves Notch1. We and others previously found that Notch1 inhibits photoreceptor formation and is required for bipolar formation (Jadhav et al., 2006; Mizeracka et al., 2013a; Yaron et al., 2006) . Analysis of mRNA levels in single cells from which Notch1 was deleted showed a strong upregulation of Blimp1 (Mizeracka et al., 2013b) . Constitutive activation of the Notch signaling pathway significantly suppressed endogenous Blimp1 expression in the retina ( Figure S7C ). These results suggest that the Notch signaling pathway, at least in part, promotes bipolar formation and inhibits rod formation via repression of Blimp1. Further studies on the relationships among bHLH genes downstream of Notch, as well as of the Notch-regulated TFs, such as Hes1, Ids, and Blimp1, will help elucidate the complete GRN that governs the rod versus bipolar cell fate specifications (Bramblett et al., 2004; Cherry et al., 2011; Mizeracka et al., 2013b; Morrow et al., 1999; Ohsawa and Kageyama, 2008) . One other regulatory mechanism that controls the level of Blimp1 is microRNA regulation via the 3 0 UTR. Previous work in other tissues showed that the microRNAs, Let7a, miR9, and miR125b, are relevant microRNAs for this negative regulation (Nie et al., 2008; West et al., 2009; Zhang et al., 2011) . Interestingly, these same microRNAs are present in the retina and likely play a role in the temporal progression of retinal cell-fate specification (La Torre et al., 2013) , perhaps in part through regulation of Blimp1.
The importance of TF dosage in cell-fate decisions has been demonstrated in several cases (Sigvardsson, 2012; Struhl et al., 1992; Taranova et al., 2006) . For example, the dosage of PU.1 regulates the B lymphocyte versus macrophage cell fates in the hematopoietic system (DeKoter and Singh, 2000) , and Ngn3 dictates endocrine differentiation in a dosage-dependent manner (Wang et al., 2010) . However, the mechanisms that regulate the levels of these TFs have not been well defined. Here, we show that the level of Otx2 is important for regulating the rod versus bipolar fates. A low level of Otx2 promotes the rod fate, whereas a high level of Otx2 induces the bipolar cell fate, and the level of Otx2 is regulated by Blimp1 in a negative-feedback loop. These findings have several implications. First, the rod and bipolar fate decision is not fixed until after the terminal mitosis, as Blimp1 protein expression is largely undetected until cell-cycle exit. Consistent with this, previous studies showed that newly postmitotic cells relied upon new transcription and translation of the Notch1 gene in order to take on a nonrod fate (Mizeracka et al., 2013a) . The data reported here show that at least a subset of newly postmitotic cells is sensitive to the levels of Otx2 for their fate decisions. Second, it has been suggested that Otx2 might be a critical positive regulator of Chx10 in bipolar cells via a distal enhancer (Kim et al., 2008a) . Thus, high Otx2 levels may promote bipolar cell formation via the activation of Chx10 (Figure 7 ). This may provide an explanation for the lag in bipolar cell differentiation relative to bipolar cell birthdays. Classical [ 3 H]-thymidine birthdating studies showed that some retinal cells born as early as P0 take on the bipolar fate, with the peak of bipolar birthdays at P4-P5 (Young, 1985a) . However, bipolar cell markers do not start to appear until P6 (Kim et al., 2008b) . This lag may be due, at least in part, to the time that is required for the Otx2 and RORb upregulate Blimp1 expression in newly postmitotic cells produced by postnatal RPCs. As its level increases, Blimp1 represses the expression of Otx2, Chx10, and Blimp1. As a result, retinal cells with low levels of Otx2 adopt the rod fate. An additional regulator in this GRN is Notch, which is transcribed in the newly postmitotic cells and inhibits Blimp1. As a result, these retinal cells obtain high levels of Otx2 and Chx10 and adopt bipolar cell fate. Otx2 might also be a critical positive regulator of Chx10 in bipolar cells via a distal enhancer, the Chx10 2.5 kb enhancer (Kim et al., 2008a) . CRMs/enhancers of the GRN are highlighted bars within each gene's horizontal representation. See also Figure S7 .
interactions among Otx2, Chx10, and other TFs to occur in the rod-bipolar GRN to fix the bipolar fate. Expression profiling studies demonstrated that there is a great amount of molecular heterogeneity among RPCs (Trimarchi et al., 2008) . Early clonal lineage analyses showed that RPCs at the same developmental stage could give rise to various clonal compositions (Turner and Cepko, 1987) . More recently, lineage studies that examined the clonal progeny of specific RPCs showed that there are distinctive types of RPCs, which are biased to produce different types of retinal cells. Olig2, a bHLH gene, was found to be expressed in the RPCs that do not make bipolar cells and rods (Hafler et al., 2012) . It will thus be of interest to determine whether Blimp1, Otx2, and Chx10 regulation might occur differently in Olig2 + and Olig2 À RPCs.
In addition to the findings regarding the rod and bipolar GRN, we report the use of two techniques. Single-molecule RNA FISH was shown to be able to detect gene expression levels in individual cells in a sensitive and quantitative manner. Because the levels of TFs can be important for developmental events, the quantitative nature of single-molecule RNA FISH makes it a valuable method for evaluating transcript levels. In addition, we showed that CRISPR/Cas9 could successfully delete targeted regions of the genome following electroporation in vivo. Deletion at the Rosa locus was very efficient, with the rates varying somewhat with the cell type. It is not clear if the lower rate seen, e.g., in bipolar cells relative to rods, might be due to the relatively lower expression of CRISPR/Cas9 in bipolar cells, as we have noted lower levels of expression in bipolar cells from the CAG promoter. Chromatin structure might be another factor that varies among cell types. Enhancer regions, often associated with low nucleosome occupancy, may make these regions relatively sensitive to CRISPR/Cas9 engineering (Buecker and Wysocka, 2012) , an asset when studying the role of such sequences.
Overall, we explored the GRN operating within late RPCs and their newly postmitotic progeny at the time when rod and bipolar cell fate decisions are being made, and we identified how TFs inputs are integrated via CRMs to control the binary cell-fate specification event. As more and more TFs and CRMs are analyzed in the context of GRNs, it should be possible to assemble relatively complete GRNs and study their precise and complex regulation by establishing computational models.
EXPERIMENTAL PROCEDURES Animals
Wild-type neonatal mice were obtained from timed pregnant CD1 mice (Charles River Laboratories). Otx2 flox/flox mice were obtained from S. Aizawa (RIKEN Center for Departmental Biology). Rosa mTmG/mTmG mice were purchased from The Jackson Laboratory (stock number 007576). All animal studies were approved by the Institutional Animal Care and Use Committee at Harvard University.
Plasmids
The CAG-EGFP, CAG-LNL-EGFP, CAG-Cre, CAG-mCherry, and CAG-LacZ plasmids were from Matsuda and Cepko (Matsuda and Cepko, 2007) . The CAG-H2bRFP was a gift from Dr. S. Tajbakhsh. The Stagia3 vector was obtained from Emerson and Cepko (Billings et al., 2010; Emerson and Cepko, 2011) . See the Supplemental Experimental Procedures and Protocol for details about the construction of all other plasmids.
In Vivo and Ex Vivo Plasmid Electroporation
Ex vivo and in vivo retina electroporation was carried out as described (Cherry et al., 2011; Matsuda and Cepko, 2007) . All ex vivo and in vivo electroporation experiments were repeated with at least three biological replicates. Plasmids were mixed in equal mass ratios and electroporated at a concentration of 500 ng/ml to 1 mg/ml per plasmid. For additional details, see the Protocol.
Histology and Immunohistochemistry
Dissected mouse retinas were prepared as previously described (Cherry et al., 2011) . A Leica CM3050S cryostat (Leica Microsystems) was used to prepare 20 mm cryosections. See the Supplemental Experimental Procedures for detailed antibody sources and dilutions. EdU detection was performed with a Click-iT EdU Alexa Fluor 594 imaging kit (C10339; Invitrogen).
Dissociation of Retina Tissues and Single-Molecule FISH
Retinal tissues were dissociated as described previously (Trimarchi et al., 2008 EMSA EMSA were performed as described previously (Kim et al., 2008a) . Roughly 1 3 10 6 293T cells were transfected with 1 mg of CAG-LacZ, CAG-Otx2, or CAG-RORb plasmid. Nuclear extracts were prepared from these cells or P3 wild-type mouse retinas using NE-PER nuclear and cytoplasmic extraction reagent kit (Pierce). Complementary oligonucleotides ( Figure 4D ) were ordered, annealed, and labeled by a DNA 3 0 End Biotinylation Kit (Pierce).
Chemiluminescent Nucleic Acid Detection Module (Pierce) was used to detect biotin-labeled probes after EMSA.
Image Analysis
All images of retinal sections were acquired by the Zeiss LSM780 inverted confocal microscope. Retina explants were imaged by Nikon Eclipse E1000 microscope. 293T cells were imaged by Leica DMI3000B inverted microscope. Images in Figures 2, 3F , and 6 were maximum projections of 5 mm tissues and were quantified by the Imaris software (Bitplane). Images in Figure 4 were quantified by calculating total fluorescent intensities of EGFP or mCherry via Fiji software.
Statistical Methods
A two-tailed Student's t test was used to compare differences between control and experimental values.
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